US Patent Issued to ALBERT EINSTEIN COLLEGE OF MEDICINE on Nov. 18 for "Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators" (New York Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,266, issued on Nov. 18, was assigned to ALBERT EINSTEIN COLLEGE OF MEDICINE (Bronx, N.Y.).

"Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators" was invented by Ana Maria Cuervo (Bronx, N.Y.) and Evripidis Gavathiotis (Flushing, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and pharmaceutically acceptable salts thereof of Formula I are disclosed. The variables, e.g. R1-R9, X, and Y are defined herein. Certain compounds and salts of Formula I are active as CMA modulators. The disclosure provides pharmaceutical compositions containing a compound of Formula I and methods of treating disorders responsive t...